drugset / Trial / NCT00413556

Changes in the Immune Response and Skin Reactivity of Grass Pollen Allergic Patients Treated With ALK Grass Tablets

NCT00413556 ↗

Phase 3 Completed 76 enrolled ALK-Abelló A/S
RandomizedParallel-groupTriple-blindTreatment

Summary

We plan to determine changes in the immune system during the allergic response to grass pollen allergens. We have chosen a particular element of the immune response, the immunoglobulin G4 (IgG4) as an indicator. We hypothesize that treatment with Grazax will increase serum levels of Phleum pratense specific IgG4 and IgE, as well as reduce the cutaneous sensitivity of the early (IgE mediated) and late (cell mediated) allergic response.

Timeline

Start
2007-01
Primary completion
2007-08
Completion
2007-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator ALK Grass tablet Unknown — —

Indications